Euro RSCG Adds More Sanofi

LOS ANGELES Havas’ Euro RSCG said it has expanded its global relationship with French pharmaceuticals giant Sanofi-Aventis and separately named Vanessa Barros vp, business development for the network’s European operations.

Barros will also supervise the Kraft business at Euro RSCG. She joined the agency in 2002 as a global account director in London, where she managed the Reckitt-Benckiser business. Prior to Euro RSCG, she worked on Reckitt and Johnson & Johnson at Publicis Groupe’s Saatchi & Saatchi.

Pierre Lecosse, CEO of Euro RSCG Europe, said, “Her international experience, her expertise on local and international accounts, her energy and contagious enthusiasm are great assets for the conquest of new business wins for Euro RSCG in Europe.”

The expansion with Sanofi-Aventis includes new assignments for Lovenox/Clexane, a leading thrombosis treatment, as well as additional work on diabetes drugs Apidra and Lantus. (Euro RSCG has handled various projects for the brands since 2004.)

In addition, Sanofi-Aventis has awarded Euro RSCG its corporate communications assignment, which covers internal editorial programs and publications. Publicis in Paris had previously handled that account.

Neither agency nor client would disclose potential spending levels.

The client spent $400 million on U.S. advertising alone in 2005 and $260 million through September 2006, per Nielsen Monitor-Plus. Global spending was not immediately available.

“This has been a great year for the agency and a wonderful way to end it,” said David Jones, agency global CEO, in a statement.

Sources said the added Sanofi-Aventis business was awarded without a pitch.

Euro RSCG has gained significant business this year from new and existing clients, including assignments from Alcatel Lucent, ExxonMobil, GlaxoSmithKline’s Boniva, LG Electronics and Reckitt.